Form 4 for CLDX Celldex Therapeutics, Inc.
Accepted 2024-06-07 00:00:00 ET · period of report 2024-06-05 · accession 0001415889-24-015950 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-07 | 2024-06-05 | CLDX | Jimenez Freddy A. | SVP, GC | M - OptEx | $10.38 | +9,540 | 35.5K | +37% | +$99.0K |
| D | 2024-06-07 | 2024-06-05 | CLDX | Jimenez Freddy A. | SVP, GC | M - OptEx | $0.00 | -9,540 | 18.5K | -34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-05 | M | A | 9,540 | $10.38 | 35,464 | D | — | — | |
| 2 | Derivative | Incentive Stock Option (Right to Buy) | 2024-06-05 | M | D | 9,540 | $0.00 | 18,454 | D | $10.38 · — to 2030-06-18 | 9,540 Common Stock | (F1) 25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. |